Juan Carlos Jaen's most recent trade in Arcus Biosciences Inc was a trade of 200,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 23, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Arcus Biosciences Inc | Juan Carlos Jaen | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 200,000 | 200,000 | - | - | Stock Option (right to buy) | |
Arcus Biosciences Inc | Juan Carlos Jaen | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 50,000 | 367,220 (0%) | 0% | 0 | Common Stock | |
Arcus Biosciences Inc | Juan Carlos Jaen | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.08 per share. | 15 Dec 2024 | 17,286 | 317,220 (0%) | 0% | 16.1 | 277,959 | Common Stock |
Arcus Biosciences Inc | Juan Carlos Jaen | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.97 per share. | 15 Jun 2024 | 6,969 | 334,506 (0%) | 0% | 17.0 | 118,264 | Common Stock |
Arcus Biosciences Inc | Juan Carlos Jaen | President | Sale of securities on an exchange or to another person at price $ 20.10 per share. | 26 Feb 2024 | 23,132 | 1,188,233 (2%) | 0% | 20.1 | 464,953 | Common Stock |
Arcus Biosciences Inc | Juan Jaen Carlos | President | Sale of securities on an exchange or to another person at price $ 20.06 per share. | 26 Feb 2024 | 3,900 | 1,211,365 (2%) | 0% | 20.1 | 78,234 | Common Stock |
Arcus Biosciences Inc | Carlos Juan Jaen | Director, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 162,400 | 162,400 | - | - | Stock Option (right to buy) | |
Arcus Biosciences Inc | Juan Jaen Carlos | Director, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 40,000 | 341,475 (0%) | 0% | 0 | Common Stock | |
Arcus Biosciences Inc | Carlos Juan Jaen | Director, President | Sale of securities on an exchange or to another person at price $ 20.09 per share. | 02 Jan 2024 | 6,975 | 1,215,265 (2%) | 0% | 20.1 | 140,128 | Common Stock |
Arcus Biosciences Inc | Carlos Juan Jaen | Director, President | Sale or transfer of securities back to the company at price $ 18.09 per share. | 18 Dec 2023 | 6,259 | 301,475 (0%) | 0% | 18.1 | 113,225 | Common Stock |
Arcus Biosciences Inc | Carlos Juan Jaen | Director, President | Sale or transfer of securities back to the company at price $ 17.74 per share. | 18 Dec 2023 | 6,128 | 307,734 (0%) | 0% | 17.7 | 108,711 | Common Stock |
Arcus Biosciences Inc | Juan Carlos Jaen | Director, President | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Jun 2023 | 6,000 | 318,682 (0%) | 0% | 0 | Common Stock | |
Arcus Biosciences Inc | Juan Carlos Jaen | Director, President | Sale or transfer of securities back to the company at price $ 19.35 per share. | 15 Jun 2023 | 4,820 | 313,862 (0%) | 0% | 19.4 | 93,267 | Common Stock |
Arcus Biosciences Inc | Juan Carlos Jaen | Director, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2023 | 185,900 | 185,900 | - | - | Stock Option (right to buy) | |
Arcus Biosciences Inc | Juan Carlos Jaen | Director, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2023 | 45,800 | 324,682 (0%) | 0% | 0 | Common Stock | |
Arcus Biosciences Inc | Juan Carlos Jaen | Director, President | Sale of securities on an exchange or to another person at price $ 30.66 per share. | 16 Dec 2022 | 3,735 | 218,959 (0%) | 0% | 30.7 | 114,515 | Common Stock |
Arcus Biosciences Inc | Juan Carlos Jaen | Director, President | Sale of securities on an exchange or to another person at price $ 31.23 per share. | 16 Dec 2022 | 701 | 218,258 (0%) | 0% | 31.2 | 21,892 | Common Stock |
Arcus Biosciences Inc | Juan Carlos Jaen | Director, President | Sale of securities on an exchange or to another person at price $ 20.72 per share. | 16 Jun 2022 | 2,333 | 212,574 (0%) | 0% | 20.7 | 48,340 | Common Stock |
Arcus Biosciences Inc | Juan Carlos Jaen | Director, President | Sale of securities on an exchange or to another person at price $ 22.29 per share. | 16 Jun 2022 | 1,789 | 210,037 (0%) | 0% | 22.3 | 39,877 | Common Stock |
Arcus Biosciences Inc | Juan Carlos Jaen | Director, President | Sale of securities on an exchange or to another person at price $ 21.71 per share. | 16 Jun 2022 | 748 | 211,826 (0%) | 0% | 21.7 | 16,239 | Common Stock |
Arcus Biosciences Inc | Juan Carlos Jaen | Director, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 125,000 | 125,000 | - | - | Stock Option (right to buy) | |
Arcus Biosciences Inc | Juan Carlos Jaen | Director, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 31,250 | 232,407 (0%) | 0% | 0 | Common Stock | |
Arcus Biosciences Inc | Juan Carlos Jaen | Director, President | Gift of securities by or to the insider at price $ 0.00 per share. | 28 Feb 2022 | 350,000 | 1,222,240 (2%) | 0% | 0 | Common Stock | |
Arcus Biosciences Inc | Juan Carlos Jaen | Director, President | Sale of securities on an exchange or to another person at price $ 39.59 per share. | 16 Dec 2021 | 632 | 202,498 (0%) | 0% | 39.6 | 25,022 | Common Stock |
Arcus Biosciences Inc | Juan Carlos Jaen | Director, President | Sale of securities on an exchange or to another person at price $ 41.42 per share. | 16 Dec 2021 | 401 | 201,157 (0%) | 0% | 41.4 | 16,611 | Common Stock |
Arcus Biosciences Inc | Juan Carlos Jaen | Director, President | Sale of securities on an exchange or to another person at price $ 40.57 per share. | 16 Dec 2021 | 304 | 201,558 (0%) | 0% | 40.6 | 12,334 | Common Stock |
Arcus Biosciences Inc | Juan Carlos Jaen | Director, President | Sale of securities on an exchange or to another person at price $ 38.79 per share. | 16 Dec 2021 | 246 | 202,019 (0%) | 0% | 38.8 | 9,542 | Common Stock |
Arcus Biosciences Inc | Juan Carlos Jaen | Director, President | Sale of securities on an exchange or to another person at price $ 40.45 per share. | 16 Dec 2021 | 233 | 202,265 (0%) | 0% | 40.5 | 9,426 | Common Stock |
Arcus Biosciences Inc | Juan Carlos Jaen | Director, President | Sale of securities on an exchange or to another person at price $ 39.67 per share. | 16 Dec 2021 | 157 | 201,862 (0%) | 0% | 39.7 | 6,228 | Common Stock |
Arcus Biosciences Inc | Juan Carlos Jaen | Director, President | Sale of securities on an exchange or to another person at price $ 23.68 per share. | 16 Jun 2021 | 2,675 | 198,286 (0%) | 0% | 23.7 | 63,344 | Common Stock |
Arcus Biosciences Inc | Juan Carlos Jaen | Director, President | Sale of securities on an exchange or to another person at price $ 24.13 per share. | 16 Jun 2021 | 2,095 | 201,048 (0%) | 0% | 24.1 | 50,552 | Common Stock |
Arcus Biosciences Inc | Juan Carlos Jaen | Director, President | Sale of securities on an exchange or to another person at price $ 24.77 per share. | 16 Jun 2021 | 87 | 200,961 (0%) | 0% | 24.8 | 2,155 | Common Stock |
Arcus Biosciences Inc | Juan Carlos Jaen | Director, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2021 | 116,250 | 116,250 | - | - | Stock Option (right to buy) | |
Arcus Biosciences Inc | Juan Carlos Jaen | Director, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2021 | 19,375 | 208,768 (0%) | 0% | 0 | Common Stock | |
Arcus Biosciences Inc | Juan Carlos Jaen | Director, President | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Oct 2020 | 1,207,000 | 1,572,240 (3%) | 2% | 0 | Common Stock | |
Arcus Biosciences Inc | Juan Carlos Jaen | Director, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2020 | 55,000 | 244,393 (0%) | 0% | 0 | Common Stock |